http://uk.biz.yahoo.com/010725/80/bzd27.html
Wednesday July 25, 10:54 AM
LONDON, July 25 (Reuters) - Ionix,
a private biotechnology firm spun out of University College London, said
on Wednesday it had secured eight million pounds ($11.4 million) of financing
to fund its work on novel painkillers.
The funding round -- the latest sign
that private equity remains ready to back biotech despite a slump in initial
public offerings -- was led by venture capital firm Apax Partners and the
Wellcome Trust medical charity.
The Cambridge-based company is working
on new types of analgesics for inflammatory and nerve-damage pain, building
on discoveries made by Professor John Wood of UCL, a leader in the role
of ion channels in pain relief.
Ionix will focus on pain associated
with chronic diseases such as osteoarthritis, rheumatoid arthritis, multiple
sclerosis and diabetic neuropathy.
Copyright © 2001 Reuters Limited